Table 2.
Characteristics | Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|---|
B | P | HR | 95%CI | B | P | HR | 95%CI | |
Gender | −0.135 | 0.691 | 0.874 | 0.451–1.695 | 0.138 | 0.701 | 1.148 | 0.568–2.321 |
Age | −0.091 | 0.731 | 0.913 | 0.543–1.534 | −0.303 | 0.303 | 0.738 | 0.414–1.316 |
Differentiation (Poor vs. well+moderate) | 0.445 | 0.114 | 1.561 | 0.899–2.709 | 0.670 | 0.023* | 1.955 | 1.099–3.478 |
pT stage (T1 + T2 vs. T3) | 0.495 | 0.142 | 1.640 | 0.847–3.175 | 0.154 | 0.674 | 1.167 | 0.569–2.391 |
Lymph node metastasis | 0.766 | 0.006* | 2.151 | 1.246–3.715 | 0.769 | 0.009* | 2.158 | 1.207–3.857 |
TNM stage (I + II vs. III + IV) | 0.629 | 0.024* | 1.875 | 1.087–3.235 | 0.150 | 0.747 | 1.162 | 0.467–2.891 |
Stromal FN content | 0.771 | 0.004* | 2.163 | 1.274–3.671 | 0.704 | 0.012 * | 2.022 | 1.169–3.498 |
*P < 0.05